Loading clinical trials...
Loading clinical trials...
Posterior Scleral Reinforcement for Adults With High Myopia
This study will evaluate the efficacy and safety of posterior scleral reinforcement on controlling myopia progression, including change in refraction, axial elongation as well as sight-threatening complications, in adults with high myopia. Half the adults will receive posterior scleral reinforcement, while the other half will receive no surgerical treatment.
Age
18 - 40 years
Sex
ALL
Healthy Volunteers
No
Start Date
April 1, 2018
Primary Completion Date
October 1, 2020
Completion Date
December 31, 2020
Last Updated
December 22, 2017
120
ESTIMATED participants
Posterior scleral reinforcement
PROCEDURE
Lead Sponsor
Beijing Tongren Hospital
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and ConditionsNCT07252687